Industry News

Industry News

Risk Of Leukemia Greater In Chernobyl Cleanup Workers; Findings May Help Estimate Cancer Risk From Low-Dose Exposures Like CT Scans

Nov 09, 2012

A 20-year study following 110,645 workers who helped clean up after the 1986 Chernobyl nuclear power plant accident in the former Soviet territory of Ukraine shows that the workers share a significant increased risk of developing leukemia... Read More

Colon Cancer Patients Who Consume Too Much Starchy, High Carbohydrate Food At Greater Risk For Cancer Recurrence

Nov 09, 2012

Colon cancer survivors whose diet is heavy in complex sugars and carbohydrate-rich foods are far more likely to have a recurrence of the disease than are patients who eat a better balance of foods, a new study by Dana-Farber Cancer Institute researchers indicates. The connection is especially strong in patients who are overweight or obese, the authors write... Read More

Patients With Aberrations In Two Genes Respond Better To Drugs Blocking A Well-Known Cancer Pathway

Nov 09, 2012

Cancer patients with mutations or variations in two genes - PIK3CA and PTEN - who have failed to respond to several, standard treatments, respond significantly better to anti-cancer drugs that inhibit these genes' pathways of action, according to research presented at the 24th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland... Read More

Thyroid Journal Publishes First Comprehensive Guidelines For Managing Anaplastic Thyroid Cancer

Nov 09, 2012

Anaplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagnosis, treatment, and long-term monitoring and follow-up care of patients with this extremely aggressive form of thyroid cancer are published in Thyroid, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers... Read More

Connection Between Popular Pain Relievers, Bladder Cancer

Nov 09, 2012

Dartmouth researchers have found that duration of ibuprofen use was associated with a reduced risk of bladder cancer in patients in northern New England, which has a high mortality rate of this disease... Read More

Alternative Weight-For-Height Measurements May Improve On Body Mass Index (BMI) For Assessing Cancer Risk

Nov 09, 2012

A study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that body mass index (BMI) - the most commonly used weight-for-height formula for estimating fatness - may not be the best measure for estimating disease risk, and particularly the risk of certain types of cancer. The study was published in the online edition of the American Journal of Epidemiology... Read More

Clots Following Joint Replacement Surgery Prevented By Aspirin

Nov 09, 2012

If you've had joint replacement surgery, it's likely you've been given warfarin, a common blood thinner and clot-preventer, prior to surgery... Read More

Clinical Trials Have Shown Anti-Tumor Activity With New Targeted Therapy For Advanced Prostate Cancer

Nov 09, 2012

Few available treatment options exist once prostate cancer has spread to other parts of the body and has failed to respond to therapies that involve blocking the male hormone androgen. Patients with advanced, hormone-refractory prostate cancer usually die from the disease after 12 to 18 months, so new therapies are desperately needed... Read More

Ovarian Cancer Death Rates Higher At Low-Volume Hospitals

Nov 09, 2012

Women who undergo surgery for ovarian cancer at hospitals with high-volume experience better results than those who have surgery at low-volume hospitals, according to researchers from the Herbert Irving Comprehensive Cancer Center (HICC) at NewYork-Presbyterian/Columbia University Medical Center and published before print in the Journal of Clinical Oncology... Read More

Microfluidic Chip Offers Fast RNA Detection From Ultra-Small Sample, Has Implications For Cancer And Alzheimer's Diagnosis

Nov 09, 2012

A new power-free microfluidic chip developed by researchers at the RIKEN Advanced Science Institute (ASI) enables detection of microRNA from extremely small sample volume in only 20 minutes. By drastically reducing the time and quantity of sample required for detection, the chip lays the groundwork for early-stage point-of-care diagnosis of diseases such as cancer and Alzheimer's... Read More

Previous Page   Next Page